APA

Bartik M. M., Baumgartel-Scofield B. A. & Mokyr M. B. (19920211). Enhanced expansion of the thymic CD8+ cell subset as a potential mechanism for the generation of enhanced antitumor cytotoxicity by thymocytes from low-dose melphalan-treated MOPC-315 tumor bearers. : Cancer immunology, immunotherapy : CII.

Chicago

Bartik M M, Baumgartel-Scofield B A and Mokyr M B. 19920211. Enhanced expansion of the thymic CD8+ cell subset as a potential mechanism for the generation of enhanced antitumor cytotoxicity by thymocytes from low-dose melphalan-treated MOPC-315 tumor bearers. : Cancer immunology, immunotherapy : CII.

Harvard

Bartik M. M., Baumgartel-Scofield B. A. and Mokyr M. B. (19920211). Enhanced expansion of the thymic CD8+ cell subset as a potential mechanism for the generation of enhanced antitumor cytotoxicity by thymocytes from low-dose melphalan-treated MOPC-315 tumor bearers. : Cancer immunology, immunotherapy : CII.

MLA

Bartik M M, Baumgartel-Scofield B A and Mokyr M B. Enhanced expansion of the thymic CD8+ cell subset as a potential mechanism for the generation of enhanced antitumor cytotoxicity by thymocytes from low-dose melphalan-treated MOPC-315 tumor bearers. : Cancer immunology, immunotherapy : CII. 19920211.